Sigma Healthcare (ASX:SIG) said that growth in its normalized earnings before taxes and interest (EBIT) for the nine months to March 31 was broadly consistent with Chemist Warehouse Group's reported 36% increase in normalized EBIT in the fiscal first half, according to a Tuesday Australian bourse filing.
Chemist Warehouse Group's normalized EBIT for the first half of fiscal 2025 came in at AU$446.1 million, compared with the AU$328.4 million reported in the prior-year period.
The company said it incurred transaction costs of AU$42.4 million up to March 31, with AU$8.1 million incurred in the first half of fiscal 2025 and AU$34.3 million incurred in the third quarter.
Sigma Healthcare's shares fell almost 6% in recent Tuesday trade.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。